Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.
about
Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsAntiparasitic therapyMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisDynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosineGenetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from AfghanistanRapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in KabulDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.Variation in clinical presentation and genotype of causative Leishmania major strain in cutaneous leishmaniasis in north and south AfghanistanSpecies-directed therapy for leishmaniasis in returning travellers: a comprehensive guideCutaneous leishmaniasis: recent developments in diagnosis and managementNoninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in childrenLeishmaniasis in the United States: treatment in 2012Optimal dosing of miltefosine in children and adults with visceral leishmaniasis.Leishmaniasis: new insights from an old and neglected disease.Therapy of vector-borne protozoan infections in nonendemic settings.Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.Balamuthia mandrillaris Encephalitis: Survival of a Child With Severe Meningoencephalitis and Review of the Literature.Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature.Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment.Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.
P2860
Q28088410-5703BBA6-B391-487D-9C7F-4DCBE37518ACQ28239164-DA3283EC-3C52-41B8-BEFA-CFCA0A7B70E8Q28271849-8F65B400-6BA3-486E-8E1D-E3A5384AC036Q28478376-B6DDB8EA-4C77-41BC-95C1-D264F37171A3Q28478944-60558786-0655-4A8E-8A1D-EB814B9CEF5DQ28539775-F6AE6E0B-75BB-419A-924C-AA95F2390B45Q30275257-ECB88D30-8ECF-4F37-AF00-06A97ADD8193Q34479028-D1C4AAF2-686E-4034-9094-C96B6BA28E94Q35065579-A6FE2A1B-BBCC-4333-BDBE-6C7A5E7F6151Q35160905-0AEE7182-8D20-4455-9084-075258D44B49Q35187729-635DBD86-0F4E-49B6-AD6D-C78C098F26E0Q35694752-6372C1BB-C864-449A-AECE-CB902C47838BQ35771790-FC71ED60-3CC3-4046-A23A-3DBCAF369123Q36086339-7F3F701A-10CC-4828-8E8C-839DC5AE3BA5Q37870821-235998E9-1B02-4CFA-8477-D3707EFEC408Q37879203-6E1A073F-AB1F-424E-9B64-4CD9E2BE7D5AQ38136837-9B7718BC-F629-43EB-851F-AD185646308DQ38205451-3DE192AD-37B0-473C-813E-B32150824918Q38511211-4D14F523-6DA9-4BBA-8FFA-87FB20F0729EQ38654933-094B83A2-5CF3-470F-8A8F-BA21C147AC5BQ38797460-B3772EEB-882B-42B1-AE53-A5E5058592BBQ39300099-5DAED6FE-E672-45AF-83A3-A280E43D16BCQ39552125-5A1DC0BA-58EA-4DB3-93E3-21824976BAD0Q43577504-432FD302-D68E-4EDD-9E96-05794CE6B1E7Q46285800-4BD00B4E-9026-4930-892E-45227CAA06CF
P2860
Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@en
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@nl
type
label
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@en
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@nl
prefLabel
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@en
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@nl
P2093
P356
P1476
Miltefosine treatment of Leish ...... ing from northern Afghanistan.
@en
P2093
A van der Sluis
H D F H Schallig
H J de Vries
J E Zeegelaar
M van Vugt
P J de Vries
P P A M van Thiel
T Leenstra
P356
10.1086/648726
P407
P577
2010-01-01T00:00:00Z